UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Meta-analysis of genome-wide SNP- and pathway-based associations for facets of neuroticism

Journal of human genetics, 2017-10, Vol.62 (10), p.903-909

2017

Volltextzugriff (PDF)

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Therapeutic advances in medical oncology, 2022-02, Vol.14, p.17588359221079125-17588359221079125

2022

Volltextzugriff (PDF)

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

Therapeutic advances in medical oncology, 2022-01, Vol.14, p.17588359221141761-17588359221141761

2022

Volltextzugriff (PDF)

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Clinical cancer research, 2021-08, Vol.27 (15), p.4397-4409

2021

Volltextzugriff (PDF)

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Cancer discovery, 2020-08, Vol.10 (8), p.1194-1209

2020

Volltextzugriff (PDF)

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

Clinical cancer research, 2020-07, Vol.26 (13), p.3287-3295

2020

Volltextzugriff (PDF)

Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort

BMC microbiology, 2017-07, Vol.17 (1), p.151-151, Article 151

2017

Volltextzugriff (PDF)

Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

Cancer, 2020-10, Vol.126 (20), p.4521-4531

2020

Volltextzugriff (PDF)

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

Scientific reports, 2019-12, Vol.9 (1), p.19909-12, Article 19909

2019

Volltextzugriff (PDF)

The Liability Threshold Model for Predicting the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Multi-Cohort Study of Korean Adults

Metabolites, 2020-12, Vol.11 (1), p.6

2020

Volltextzugriff (PDF)

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Cancer medicine (Malden, MA), 2021-10, Vol.10 (20), p.7012-7020

2021

Volltextzugriff (PDF)

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

Frontiers in oncology, 2022-03, Vol.12, p.821391-821391

2022

Volltextzugriff (PDF)

Male-specific genetic effect on hypertension and metabolic disorders

Human genetics, 2014-03, Vol.133 (3), p.311-319

2014

Volltextzugriff (PDF)

Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia

BMC medical genetics, 2017-03, Vol.18 (1), p.23-23, Article 23

2017

Volltextzugriff (PDF)

Novel Genetic Variants Associated with Lumbar Spondylosis in Koreans : A Genome-Wide Association Study

대한신경외과학회지, 2018, 61(1), , pp.66-74

2018

Volltextzugriff (PDF)

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Clinical & translational immunology, 2022, Vol.11 (1), p.e1364-n/a

2022

Volltextzugriff (PDF)

Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

Clinical cancer research, 2023-01, Vol.29 (1), p.221-232

2023

Volltextzugriff (PDF)

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

Journal of clinical oncology, 2024-02, Vol.42 (5), p.507-517

2024

Volltextzugriff (PDF)

Genetic risk prediction for normal-karyotype acute myeloid leukemia using whole-exome sequencing

Genomics & Informatics, 2013, 11(1), , pp.46-51

2013

Volltextzugriff (PDF)

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

European journal of cancer (1990), 2021-08, Vol.153, p.179-189

2021

Volltextzugriff (PDF)

Abstract 2755: Single-cell RNA sequencing reveals priming professional antigen-presenting macrophages and chemokine expressing T cells in tumor microenvironment by AXL inhibitor, SKI-G-801

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2755-2755

2021

Volltextzugriff (PDF)

Repotrectinib exhibits potent anti-tumor activity in treatment-naive and solvent-front-mutant ROS1-rearranged non-small cell lung cancer

Clinical cancer research, 2020-04, Vol.26 (13), p.3287-3295

2020

Volltextzugriff (PDF)

Abstract 6543: Comparative analysis of immune landscape according to EGFR mutation and tumor PD-L1 proportion scores in non-small cell lung cancer at single cell resolution

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6543-6543

2023

Volltextzugriff (PDF)

Novel Genetic Variants Associated with Lumbar Spondylosis in Koreans : A Genome-Wide Association Study

Journal of Korean Neurosurgical Society, 2018, Vol.61 (1), p.66-74

2018

Volltextzugriff (PDF)

Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.LB544-LB544

2022

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(89)

Publikationsform

Artikel
(99)

Sprache

Englisch
(80)
Koreanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Life Sciences & Biomedicine
(45)
Humans
(20)
Oncology
(12)
Female
(11)
Male
(10)
Middle Aged
(10)
Mutation
(10)
Adult
(9)
Physical Sciences
(9)
Chemistry
(8)
Food Science & Technology
(8)
Patients
(8)
Aged
(7)
Biological And Medical Sciences
(7)
Food Industries
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Original
(6)
Polyphenols
(6)
Science & Technology - Other Topics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Meta-analysis of genome-wide SNP- and pathway-based associations for facets of neuroticism

Molecular landscape of osimertinib resistance in patients and patient-derived preclinical models

Plasma tumor mutation burden is associated with clinical benefit in patients with non-small cell lung cancer treated with anti-programmed death-1 monotherapy

Modeling Clinical Responses to Targeted Therapies by Patient-Derived Organoids of Advanced Lung Adenocarcinoma

Antitumor Activity of Amivantamab (JNJ-61186372), an EGFR–MET Bispecific Antibody, in Diverse Models of EGFR Exon 20 Insertion–Driven NSCLC

Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer

Comparative analysis of gut microbiota associated with body mass index in a large Korean cohort

Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma

Patient-Derived Cells to Guide Targeted Therapy for Advanced Lung Adenocarcinoma

The Liability Threshold Model for Predicting the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Multi-Cohort Study of Korean Adults

A phase II study of poziotinib in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Incorporation of SKI-G-801, a Novel AXL Inhibitor, With Anti-PD-1 Plus Chemotherapy Improves Anti-Tumor Activity and Survival by Enhancing T Cell Immunity

Male-specific genetic effect on hypertension and metabolic disorders

Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia

Novel Genetic Variants Associated with Lumbar Spondylosis in Koreans : A Genome-Wide Association Study

SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models

Preclinical Study of a Biparatopic METxMET Antibody-Drug Conjugate, REGN5093-M114, Overcomes MET-driven Acquired Resistance to EGFR TKIs in EGFR-mutant NSCLC

Personalized Biomarker-Based Umbrella Trial for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: KCSG HN 15-16 TRIUMPH Trial

Genetic risk prediction for normal-karyotype acute myeloid leukemia using whole-exome sequencing

Clinical decision support algorithm based on machine learning to assess the clinical response to anti–programmed death-1 therapy in patients with non–small-cell lung cancer

Abstract 2755: Single-cell RNA sequencing reveals priming professional antigen-presenting macrophages and chemokine expressing T cells in tumor microenvironment by AXL inhibitor, SKI-G-801

Repotrectinib exhibits potent anti-tumor activity in treatment-naive and solvent-front-mutant ROS1-rearranged non-small cell lung cancer

Abstract 6543: Comparative analysis of immune landscape according to EGFR mutation and tumor PD-L1 proportion scores in non-small cell lung cancer at single cell resolution

Novel Genetic Variants Associated with Lumbar Spondylosis in Koreans : A Genome-Wide Association Study

Abstract LB544: Targeting adaptive metabolic program as a novel treatment approach for TKIs-failed ALK-positive NSCLCs

Suchergebnisse filtern